PureTech News | PureTech Health

Press releases

News Category

Year

Press Releases - 2021-12-08

Seaport

PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions

Continue

Press Releases - 2021-12-07

Seaport

PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions

Continue

Press Releases - 2021-11-16

Wholly Owned Pipeline - LYT-100

PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates

Continue

Press Releases - 2021-11-15

Other

PureTech Announces Participation in Two Upcoming Investor Conferences

Continue

Press Releases - 2021-11-12

Gallop Oncology – LYT-200

PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Continue

Press Releases - 2021-11-11

Gallop Oncology – LYT-200

PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer

Continue

Press Releases - 2021-11-10

Other

Karuna

PureTech Receives Approximately $100 Million from Sale of a Portion of Founded Entity Shares

Continue

Press Releases - 2021-11-09

Karuna

PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China

Continue

Press Releases - 2021-11-09

Other

PureTech Announces Participation at the Jefferies London Healthcare Conference

Continue

Press Releases - 2021-10-14

Vedanta

PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary

Continue